Simplify Health Care ETF Rating $30.59 +0.17 (+0.56%) (As of 12/17/2024 ET) Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOwnershipRatings Simplify Health Care ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PINK Aggregate RatingModerate Buy 2.74Holdings in PINK have an aggregate rating of Moderate Buy based on 751 analyst ratings issued in the past year covering 50 companies (99.9% of the portfolio).PINK Aggregate Price Target$30.59High Prediction$30.59Average Prediction$30.59Low Prediction$30.59Holdings in PINK have an aggregate price target of $30.59 and a range of $30.59 to $30.59 covering 50 companies (99.9% of the portfolio).PINK Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy8 Buy rating(s)Moderate Buy36 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Simplify Health Care ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 50 PINK Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings10.07%PCTPureCycle Technologies$11.68-1.7%0.5432 of 5 stars2.50$10.60 -9.2%6News Coverage6.45%RMDResMed$242.62+0.7%4.6286 of 5 stars2.46$227.91 -6.1%13Analyst RevisionPositive News6.11%CIThe Cigna Group$265.51-2.8%4.9993 of 5 stars3.00$394.64 48.6%15Short Interest ↓Gap DownHigh Trading Volume5.29%UNHUnitedHealth Group$485.52-2.6%4.9958 of 5 stars2.95$626.84 29.1%22Gap DownHigh Trading Volume4.92%LLYEli Lilly and Company$778.30-0.1%4.9945 of 5 stars2.81$1,002.22 28.8%21Buyback Announcement4.87%ISRGIntuitive Surgical$545.16+0.6%4.7706 of 5 stars2.74$550.28 0.9%19Positive News4.39%DXCMDexCom$77.80+1.8%4.9889 of 5 stars2.72$98.00 26.0%18Short Interest ↓4.34%JNJJohnson & Johnson$146.39+1.8%4.9217 of 5 stars2.50$174.73 19.4%14Positive News3.79%ADMAADMA Biologics$18.63-1.8%3.8603 of 5 stars3.25$21.25 14.1%4Short Interest ↓3.30%EWEdwards Lifesciences$74.15+0.3%3.9972 of 5 stars2.42$79.40 7.1%26Analyst UpgradeInsider TradeAnalyst Revision3.08%REGNRegeneron Pharmaceuticals$740.01+2.1%4.7125 of 5 stars2.73$1,052.90 42.3%22Analyst Forecast3.02%TMOThermo Fisher Scientific$528.71-0.3%4.8614 of 5 stars2.86$652.30 23.4%21Analyst RevisionPositive News2.79%SRPTSarepta Therapeutics$125.76-0.8%4.9058 of 5 stars2.91$178.71 42.1%22Insider TradePositive News2.75%GILDGilead Sciences$92.80+0.8%4.5379 of 5 stars2.67$96.43 3.9%27Insider Trade2.68%CHWYChewy$33.61+0.2%3.9206 of 5 stars2.61$34.60 2.9%23Analyst Forecast2.42%VRTXVertex Pharmaceuticals$469.24+0.2%4.2033 of 5 stars2.55$505.73 7.8%31Analyst ForecastPositive News2.24%PRAXPraxis Precision Medicines$73.01+0.9%2.4854 of 5 stars2.89$146.33 100.4%9High Trading Volume2.24%MMM3M$128.05-1.1%4.6972 of 5 stars2.56$144.87 13.1%16Positive News2.01%ICLRICON Public$203.26-0.5%4.2939 of 5 stars2.85$290.20 42.8%131.70%ABTAbbott Laboratories$113.29+0.6%4.9349 of 5 stars2.73$130.71 15.4%15Dividend Increase1.59%TFXTeleflex$178.28+0.6%4.9092 of 5 stars2.63$259.00 45.3%8Analyst Forecast1.45%CASHPathward Financial$80.30-2.6%2.0867 of 5 stars2.50$86.00 7.1%2Positive News1.43%ESTAEstablishment Labs$44.67-2.5%2.8057 of 5 stars3.00$60.60 35.7%5Positive News1.28%CVSCVS Health$44.04-5.5%5 of 5 stars2.70$70.50 60.1%20High Trading Volume1.27%SNYSanofi$48.94+6.6%3.671 of 5 stars3.00$57.50 17.5%3News CoverageGap UpHigh Trading Volume1.26%TNDMTandem Diabetes Care$34.23+1.9%4.6425 of 5 stars2.83$53.81 57.2%18Positive News1.20%LPTXLeap Therapeutics$3.11+3.3%2.1538 of 5 stars3.00$7.50 141.2%3Positive News1.20%RVTYRevvity$114.75-0.4%3.9594 of 5 stars2.75$132.47 15.4%16Positive News1.14%ITCIIntra-Cellular Therapies$86.96+2.2%4.1678 of 5 stars2.85$97.23 11.8%131.06%ALHCAlignment Healthcare$10.83-3.4%0.6922 of 5 stars2.83$11.44 5.7%121.06%RPRXRoyalty Pharma$25.12+0.5%4.7144 of 5 stars2.83$41.67 65.9%60.99%LEGNLegend Biotech$34.68+5.1%1.6722 of 5 stars3.00$81.54 135.1%130.83%IQVIQVIA$196.64-0.2%4.9238 of 5 stars2.90$256.19 30.3%20Short Interest ↓Analyst Revision0.75%EXASExact Sciences$60.37-0.6%4.6071 of 5 stars2.94$72.94 20.8%180.74%AKROAkero Therapeutics$30.61+4.7%3.958 of 5 stars2.88$46.83 53.0%8Short Interest ↓0.64%ARGXargenx$638.33+0.9%3.1118 of 5 stars2.91$635.11 -0.5%22Short Interest ↓Positive News0.54%ARQTArcutis Biotherapeutics$14.86+9.5%0.7957 of 5 stars2.75$15.50 4.3%4Options Volume0.53%FULCFulcrum Therapeutics$4.54+2.7%2.0832 of 5 stars2.20$9.33 105.6%10Positive News0.49%BNTCBenitec Biopharma$12.77+1.5%3.6558 of 5 stars3.22$24.43 91.3%9Analyst ForecastShort Interest ↑0.31%LIVNLivaNova$49.94-0.4%3.9587 of 5 stars3.00$69.17 38.5%7Analyst UpgradePositive News0.31%SYKStryker$370.75-0.5%4.9058 of 5 stars2.85$404.35 9.1%20Positive News0.30%SNDXSyndax Pharmaceuticals$13.63-1.2%3.9655 of 5 stars2.91$37.64 176.1%11High Trading Volume0.24%TECHBio-Techne$75.27-1.2%4.3197 of 5 stars2.63$82.00 8.9%8Short Interest ↑Positive News0.24%BMRNBioMarin Pharmaceutical$67.19+2.5%4.9882 of 5 stars2.74$94.20 40.2%23Positive News0.21%DHRDanaher$233.53-0.3%4.8559 of 5 stars2.79$287.95 23.3%19Short Interest ↑Analyst Revision0.16%ZBHZimmer Biomet$108.08+1.2%4.7243 of 5 stars2.25$123.28 14.1%20Analyst Upgrade0.15%AGLagilon health$2.01-8.7%2.4276 of 5 stars1.95$4.28 113.6%21Analyst ForecastShort Interest ↑News Coverage0.04%BSXBoston Scientific$90.41-0.1%4.5351 of 5 stars2.91$95.52 5.7%23Analyst ForecastShort Interest ↑0.03%VLTOVeralto$103.45-0.7%2.5582 of 5 stars2.50$109.50 5.8%120.02%BMYBristol-Myers Squibb$57.65+3.2%4.8254 of 5 stars2.25$55.64 -3.5%20Dividend IncreaseAnalyst UpgradePositive News This page (NYSEARCA:PINK) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Simplify Health Care ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Simplify Health Care ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
